Loading…
Paradeep Phosphates (PARADEEP)₹139.92−2.12%Fertilizers
In the Sep 2026 quarter (consolidated), Paradeep Phosphates reported sales of ₹7,377 Cr, up 7.1% from Sep 2025, and net profit of ₹121 Cr, down 64.6% year on year. For the year to Mar 2026, sales were ₹21,885 Cr and net profit ₹993 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,601 | 2,246 | 2,382 | 4,630 | 4,998 | 4,202 | 4,516 | 6,885 | 5,757 | 4,715 | 6,133 | 7,377 |
| Expenses | 2,311 | 2,094 | 2,230 | 4,111 | 4,551 | 3,812 | 3,920 | 6,216 | 5,274 | 4,259 | 5,405 | 6,948 |
| Operating Profit | 281 | 147 | 145 | 505 | 436 | 382 | 578 | 654 | 470 | 440 | 718 | 412 |
| OPM % | 11.0% | 7.0% | 6.0% | 10.9% | 9.0% | 9.0% | 13.0% | 10.0% | 8.0% | 8.9% | 11.9% | 6.0% |
| Other Income | 9.01 | 30.99 | 18.99 | 19.98 | 41.95 | 59.94 | 34.01 | 41.98 | −9.99 | 41.98 | 42.98 | 18.01 |
| Interest | 82.01 | 95.04 | 91.01 | 105 | 103 | 119 | 104 | 140 | 127 | 156 | 132 | 158 |
| Depreciation | 54.85 | 57.89 | 60.84 | 85.83 | 87.81 | 85.85 | 85.80 | 89.72 | 102 | 126 | 106 | 109 |
| Profit before tax | 154 | 26.10 | 13.05 | 338 | 290 | 239 | 426 | 471 | 234 | 203 | 528 | 165 |
| Tax % | 29.0% | 18.0% | 59.0% | 24.0% | 28.0% | 28.0% | 25.0% | 27.0% | 22.0% | 23.0% | 25.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −32.07 | 1.01 | 16.02 | 0.00 |
| Net Profit | 109 | 21.94 | 4.98 | 254 | 208 | 171 | 316 | 341 | 181 | 156 | 392 | 121 |
| EPS (Rs) | 1.33 | 0.25 | 0.06 | 3.12 | 2.56 | 2.10 | 3.87 | 4.18 | 1.74 | 1.49 | 3.77 | 1.16 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,364 | 4,200 | 5,176 | 7,876 | 13,377 | 11,589 | 16,990 | 21,885 | 23,982 |
| Expenses | 3,906 | 3,725 | 4,617 | 7,171 | 12,512 | 10,896 | 15,390 | 19,615 | 21,886 |
| Operating Profit | 450 | 465 | 547 | 681 | 812 | 669 | 1,569 | 2,199 | 2,040 |
| OPM % | 10.0% | 11.0% | 10.9% | 9.0% | 6.0% | 6.0% | 9.0% | 9.9% | 8.5% |
| Other Income | 29.01 | 26.97 | 11.99 | 27.01 | 75.93 | 44.99 | 124 | 50.97 | 92.98 |
| Interest | 159 | 192 | 111 | 86.04 | 291 | 366 | 443 | 528 | 573 |
| Depreciation | 69.81 | 71.79 | 82.80 | 89.76 | 175 | 211 | 343 | 402 | 442 |
| Profit before tax | 252 | 231 | 367 | 537 | 427 | 142 | 914 | 1,333 | 1,129 |
| Tax % | 37.0% | 16.0% | 39.0% | 26.0% | 29.0% | 29.0% | 27.0% | 25.0% | — |
| Exceptional items | −6.01 | −7.01 | −4.01 | −5.01 | −10.03 | −16.03 | 10.03 | −27.07 | −15.04 |
| Net Profit | 159 | 192 | 222 | 397 | 303 | 99.74 | 660 | 993 | 849 |
| EPS (Rs) | 2.75 | 3.35 | 3.87 | 6.91 | 3.72 | 1.22 | 8.11 | 9.58 | 8.16 |
| Dividend payout % | 36.1% | 0.0% | 0.0% | 0.0% | 13.1% | 41.1% | 12.0% | 16.1% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 576 | 576 | 576 | 577 | 815 | 816 | 817 | 1,041 |
| Reserves | 906 | 1,028 | 1,251 | 1,650 | 2,689 | 2,747 | 5,060 | 5,742 |
| Borrowings | 3,116 | 2,291 | 1,248 | 2,948 | 4,632 | 4,001 | 5,083 | 6,882 |
| Other Liabilities | 1,025 | 1,114 | 1,342 | 2,755 | 2,513 | 2,092 | 3,310 | 4,252 |
| Total Liabilities | 5,625 | 5,009 | 4,419 | 7,930 | 10,650 | 9,655 | 14,269 | 17,917 |
| Fixed Assets | 1,022 | 1,212 | 1,224 | 1,259 | 2,871 | 3,428 | 5,192 | 6,018 |
| CWIP | 255 | 149 | 220 | 336 | 697 | 372 | 584 | 424 |
| Investments | 0.00 | 3.01 | 125 | 555 | 3.01 | 3.01 | 273 | 25.09 |
| Other Assets | 4,347 | 3,645 | 2,849 | 5,780 | 7,080 | 5,852 | 8,220 | 11,450 |
| Inventories | 1,422 | 1,080 | 900 | 2,293 | 2,241 | 1,834 | 2,559 | 4,627 |
| Trade receivables | 2,336 | 2,144 | 1,153 | 899 | 3,677 | 2,710 | 3,056 | 4,772 |
| Cash & equivalents | 19.94 | 5.98 | 92.73 | 596 | 110 | 118 | 1,033 | 391 |
| Total Assets | 5,625 | 5,009 | 4,419 | 7,930 | 10,650 | 9,655 | 14,269 | 17,917 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −920 | 1,269 | 1,500 | −43.99 | −2,377 | 1,436 | 1,647 | −1,011 |
| Cash from investing activity | −103 | −144 | −290 | −1,103 | −421 | −369 | −417 | −559 |
| Cash from financing activity | 1,020 | −1,144 | −1,127 | 1,593 | 2,305 | −1,025 | −390 | 1,000 |
| Net cash flow | −4.99 | −14.99 | 87.06 | 446 | −495 | 48.01 | 844 | −570 |
| Capex | 126 | 139 | 169 | 619 | 435 | 412 | 457 | 867 |
| Free cash flow | −1,048 | 1,132 | 1,333 | −665 | −2,814 | 1,027 | 1,192 | −1,878 |
| CFO / OP % | −196.0% | 278.0% | 288.0% | 6.0% | −274.0% | 222.0% | 117.0% | −33.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 196 | 187 | 82 | 42 | 101 | 86 | 66 | 80 |
| Inventory days | 166 | 134 | 85 | 133 | 77 | 74 | 78 | 105 |
| Days payable | 84 | 101 | 90 | 133 | 67 | 61 | 72 | 71 |
| Cash conversion cycle | 280 | 221 | 78 | 43 | 112 | 100 | 74 | 115 |
| Working capital days | 36 | 34 | 26 | −49 | 15 | 14 | −2 | 19 |
| ROCE % | — | 10.0% | 14.0% | 15.0% | 11.0% | 7.0% | 15.0% | 15.0% |
For the Sep 2026 quarter, Paradeep Phosphates reported sales of ₹7,377 Cr, up 7.1% year on year and net profit of ₹121 Cr, down 64.6% year on year. The operating margin was 6.0%.
Paradeep Phosphates' sales for the year to Mar 2026 were ₹21,885 Cr; over the last twelve months they were ₹23,982 Cr.
Net profit for the year to Mar 2026 was ₹993 Cr, and ₹849 Cr over the last twelve months. Earnings per share over the same trailing period were ₹8.16.
Paradeep Phosphates reported borrowings of ₹6,882 Cr at Mar 2026, against cash and equivalents of ₹391 Cr.
Cash from operations was −₹1,011 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1,878 Cr.